Abstract
A group of 23 patients with advanced head and neck cancer were treated with highly selective intra-arterial (IA) cisplatin 150 mg/m2 delivered rapidly through microcatheters. The systemic effects of cisplatin were neutralized by concurrent administration of sodium thiosulfate. Two-to-threefold higher tumor platinum contents were detected in tumor biopsies after selective IA cisplatin administration compared to historicol controls (treated with 100 mg/m2 IA). Cisplatin-induced DNA modification in human tumor biopsies was quantitated using the antiserum NKI-A59. High levels of cisplatin DNA adducts were detected which correlated linearly with the tumor platinum content (r 2=0.62). The addition of radiotherapy to this high dose intensity cisplatin treatment resulted in a 92% complete response (CR) rate (12 of 13 patients achieved a CR). Since no difference in tumor platinum content was detected between patients receiving or not receiving radiotherapy (13 and 10 patients, respectively), but the response rate was substantially different (12 CR and 1 partial response with radiotherapy versus 6 partial and 4 non-responders without radiotherapy), these data suggest that the high platinum levels achieved by selective IA infusion were sufficient to produce enough interaction with radiotherapy to cause a 92% CR rate. Whether this interaction is additive or synergistic is as yet unclear.
Similar content being viewed by others
References
Andrew PA, Murphy MP, Howell SB (1989) Characterization of cisplatin-resistant Colo 316 human ovarian carcinoma cells. Eur J Cancer Clin Oncol 25:619–625
Andrew PA, Jones JA, Varki NM, Howell SB (1989) Rapid emergence of acquired cis-diamminedichloroplatinum(II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun 2:93–100
Bartelink H, Kallman RF, Rapacchietta D, Hart GAM (1986) Therapeutic enhancement in mice by clinically relevant dose of fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation. Radiother Oncol 6:61–74
Begg AC, Kolk PJ van der, Dewit L, Bartelink H (1986) Radiosensitization by cisplatin of RIF1 tumor cells in vitro. Int J Radiat Biol 50:871–884
Blommaert FA, Michael C, Terheggen MAB, Muggia FM, Kortes V, Schornagel JH, Hart AAM, Engelse L den (1993) Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response. Cancer Res 53:5669–5675
Cachin Y, Eschwege F (1975) Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev. 2:177–191
Coia LR (1993) The use of mitomycin in esophageal cancer. Oncology 50 [Suppl 1]:53–60
Gouyette A, Apchin A, Foka M, Richard JM (1986) Pharmacokinetics of intra-arterial and intravenous cisplatin in head and neck cancer patients. Eur J Cancer Clin Oncol 22:257–263
Hryniuk WM (1988) The importance of dose intensity in the outcome of chemotherapy. In: Hellman S, DeVita V, Rosenburg SJB (eds) Advances in oncology. Lippincott Company, Philadelphia, pp 121–141
Jacobs C (1989) Adjuvant chemotherapy for head and neck cancer. J Clin Oncol 7:823–826
Kerr DJ, Los G (1993) Pharmacokinetic principles of locoregional chemotherapy. Cancer Surv 17:105–122
Log, Muggia FM (1994) Platinum resistance: experimental and clinical status. Hematol Oncol Clin North Am 8:411–429
Los G, Mutsaers PHA, Van der Vijgh WJF, Baldew GS, De Graaf PW, McVie JG (1989) Direct diffusion of cis-diammine chloroplatinum (II) in intraperitoneal tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49:3380–3384
Los G, Vugt MJH van, Pinedo HM (1994) Response of peritoneal solid tumors after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer 69: 235–241
Los G, Vicario D, Barton RM, Blommaert FA, Engelse L den, Heath DD, Weisman R, Hanchett CA, Robbins KT Howell SB (1994) Selective intra-arterial (i.a.) infusion of high dose cisplatin (cddp) in advanced head and neck cancer patients results in high tumor platinum (Pt) concentrations and cisplatin DNA adduct formation. Proc Am Soc Clin Oncol. 13:282
Mäenpää J, Sipilä, P, Kangas L, Karnani P, Grönroos M (1992) Chemosensitizing effect of an antiestrogen, toremifene, on ovarian cancer. Gynecol Oncol 46:292–297
McClay EF, Mastrangelo MJ, Bellet RE, Berd D (1989) The importance of tamoxifen to a cisplatin containing regimen in the treatment of malignant melanoma. Cancer 63:1292–1295
Nakata B, Albright KD, Barton RM, Howell SB, Los G (1995) Synergistic interaction between cisplatin and tamoxifen and the delay of cisplatin resistance in head and neck carcinoma cell lines. Cancer Chemother Pharmacol 35:511–518
Oldenburg J, Begg AC, Vugt MJH van, Ruevekamp M, Schornagel JH, Pinedo HM, Los G (1994) Characterization of resistance mechanism to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colonic adenocarcinoma cell line in vitro. Cancer Res 54:487–493
Reed E, Parker RJ, Gill I, Bicher A, Dabholkar M, Vionnet JA, Bostick-Bruton F, Tarone R, Muggia FM (1993) Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies. Cancer Res 3694–3699
Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G, Howell SB (1994) Phase I study of highly selective supradose cisplatin infusion for advanced head and neck cancer. J Clin Oncol 12:2113–2120
Robbins KT, Vicario D, Seagren S, Weisman R, Pelliteri P, Kerber C, Los G, Howell SB (1994) A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 168:419–422
Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E III (1987) Characterization of a human squamous carcinoma cell line resistance to cis-diamminedichloroplatinum(II). Cancer Res 47:388–393
Troger V, Fischel JL, Formento P, Gioanni J, Milano G (1992) Effects of prolonged exposure to cisplatin on cytotoxicity and intracellular drug concentration. Eur J Cancer 28:82–86
Vikram B, Strong EW, Shah J, Spiro RH (1980) Elective postoperative radiation therapy in states III and IV epidermoid carcinoma of the head and neck. Am J Surg 140: 580–584
Von Hoff DD, Clark GM, Weiss GR, Marchall MH, Buchok JB, Knight WA, LeMaistre CF (1986) Use of in vitro dose response effects to select antineoplastics for high dose or regional administration regimens. J Clin Oncol 4: 1827–1834
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Los, G., Blommaert, F.A., Barton, R. et al. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation. Cancer Chemother. Pharmacol. 37, 150–154 (1995). https://doi.org/10.1007/BF00685642
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00685642